NovaDel Pharma Inc.
25 Minneakoning Road
Flemington
New Jersey
08822
United States
Tel: 908-782-3431
Fax: 908-782-2445
Website: http://www.novadel.com/
118 articles about NovaDel Pharma Inc.
-
The End of the Road: New Jersey's NovaDel Pharma to Dissolve
2/24/2017
-
NovaDel Pharma Reports Resolution Of Contingent Liabilities
2/5/2016
-
NovaDel Pharma Announces The Sale Of Its Zolpimist® New Drug Application, License And Intellectual Property To Amherst Pharmaceuticals
9/22/2014
-
NovaDel Pharma Announces Proposed Actions To Complete Liquidation Of Assets And Cash Distribution To Shareholders
3/26/2014
-
NovaDel Pharma Announces The Sale Of Its Nitromist® New Drug Application, License And Intellectual Property To Mist Pharmaceuticals, LLC.
11/20/2013
-
NovaDel Pharma Announces Completion of the Sale of Substantially All Assets to Suda Ltd.
8/14/2013
-
NovaDel Pharma Announces Stockholder Approval of Sale of Substantially All Assets to Suda Ltd.
7/22/2013
-
NovaDel Pharma Announces Adjournment of Special Stockholder Meeting
6/27/2013
-
NovaDel Pharma Announces the Signing of a Definitive Agreement to Sell Its NovaMist Technology and Certain Other Assets
4/8/2013
-
NovaDel Pharma Announces Preliminary Agreement to Sell its NovaMist Technology
12/27/2012
-
NovaDel Pharma Reports Unaudited Financial Results for the Nine Months Ended September 30, 2012
11/15/2012
-
NovaDel Pharma Reports Unaudited Financial Results for the Six Months Ended June 30, 2012
8/1/2012
-
NovaDel Pharma Reports Unaudited Financial Results for Fourth Quarter and Year Ended December 31, 2011
3/21/2012
-
NovaDel Pharma Announces Termination of License Agreements for Ondansetron Oral Spray Product
1/23/2012
-
NovaDel Pharma Continuing to Explore Strategic Alternatives
1/19/2012
-
NovaDel Pharma Reports Financial Results for Third Quarter 2011
11/2/2011
-
NovaDel Pharma Reports Financial Results for Third Quarter 2011
11/2/2011
-
NovaDel Pharma Recent Events
8/30/2011
-
NovaDel Pharma Signs Exclusive License and Distribution Agreement with Rechon Life Science to Manufacture and Commercialize Zolpimist® Outside the US and Canada
8/22/2011
-
NovaDel Pharma Reports Financial Results for Second Quarter 2011
8/15/2011